Morgan Stanley Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $45

Futu NewsNov 11 21:31 · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT), Pharvaris (PHVS) and Tandem Diabetes Care (TNDM)

TipRanksNov 11 21:21 · Ratings

Assessing MedTech Impact From Potential China Tariffs

Seeking AlphaNov 10 00:28

Barclays Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $60

Futu NewsNov 9 16:33 · Ratings

A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $40 to $75

Futu NewsNov 8 21:00 · Ratings

Here's What Analysts Are Forecasting For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Results

Simply Wall StNov 8 18:03